These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7859771

  • 21. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors].
    Okuyama T, Suzuki H, Nakamoto K, Suzuki S.
    Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
    Ozcan Z, Burak Z, Kumanlioğlu K, Sabah D, Başdemir G, Bilkay B, Cetingül N, Ozkiliç H.
    Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
    [Abstract] [Full Text] [Related]

  • 24. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
    Matsui R, Komori T, Nakata Y, Doi K, Tabuchi K, Saika Y, Utsunomiya K, Adachi I, Shimizu T, Sueyoshi K, Narabayashi I, Morishita S.
    Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The role of Tc-99m MDP and Ga-67 imaging in the clinical evaluation of malignant fibrous histiocytoma.
    Lin WY, Kao CH, Hsu CY, Liao SQ, Wang SJ, Yeh SH.
    Clin Nucl Med; 1994 Nov; 19(11):996-1000. PubMed ID: 7842598
    [Abstract] [Full Text] [Related]

  • 30. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
    Sato O, Kawai A, Ozaki T, Kunisada T, Danura T, Inoue H.
    J Orthop Sci; 1998 Nov; 3(6):297-303. PubMed ID: 9811980
    [Abstract] [Full Text] [Related]

  • 31. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
    Dancheva Z, Bochev P, Chaushev B, Yordanova T, Klisarova A.
    Nucl Med Rev Cent East Eur; 2016 Nov; 19(1):22-7. PubMed ID: 26841376
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
    Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ.
    Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.
    Van Laere K, Casier K, Uyttendaele D, Mondelaers W, De Sadeleer C, Simons M, Dierckx R.
    J Nucl Med; 1998 Sep; 39(9):1563-9. PubMed ID: 9744344
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.